News + Font Resize -

DCA bans 16 categories of drugs of sub-standard quality, advise public against using them
Our Bureau, Hyderabad | Thursday, June 26, 2003, 08:00 Hrs  [IST]

The officials of the Drug Control Administration on Wednesday seized certain batches of 16 categories of drugs that were found to be not of standard quality. The Additional Director-General of Drug Control Administration, P Ananthasayanam Reddy, while releasing the list of the 16 drugs, advised hospitals, doctors, healthcare institutions, medical shops and also the general public against using them.

In a press release, Reddy listed 16 drugs manufactured by various pharmaceutical companies that do not contain the prescribed quantity of ingredients and chemical compounds.

The names of the drugs and its manufacturers, along with the batch number in bracket, are given below.

Tonovit syrup, Richer Drugs, Hyderabad (2024), Centzee syrup, Maxwell Healthcare, Kandivli, Mumbai (MW 11102), Medigrip, Precision Coatings, Pithampur, MP (10), Sarpicillin suspension, Sarpin Pharmacal, Nadiad (153), Marcgrow syrup, Barhem Pharma, Aurangabad (mcw-101), Ampicillin Sod injection, Jackson Labs, Amritsar (6732), Oxytetracycline HCL Animal form tabs, Rac Remedies Pharmaceuticals, Ujjain (90), Coryzan Expectorant, Artichem Labs, Ahmednagar (5s203).

Two drugs from Thane-based manufacturers, one being Sultrim suspension, Meridian Drug House (BP-154)and Metronidazole Benzoate oral suspension, Sarvodaya Labs (MTS-22002) were listed.

Other drugs included Rifazi-a-forte, Acichem Labs (220), S’Cold Strong, Stanley Chemicals (107), both Mumbai-based.

Gentareye drops, RR Labs (022 and 023), Syrup Myloport, Elida Healthcare (3013), Papzyme syrup, Syndicate Pharma (221), and BG Plex, Bonafide Labs (21) were on the list of inferior quality drugs from Indore, in Madhya Pradesh.

Post Your Comment

 

Enquiry Form